There are two types of dialysis. Although most people think of center-based hemodialysis as the primary treatment for ...

As children, Amaris and Dominique Elston were inseparable. When Dominique needed a kidney, Amaris immediately wanted to ...

Given her family's history of kidney failure, Amaris, who was then applying for medical school, was unclear about her ...

By Jula Inrig, M.D. Chief Medical Officer, Travere Therapeutics | When a specialized field of medicine has long been quiet, a ...

DEAR DR. ROACH: I am a 62-year-old female who has focal segmental glomerulosclerosis (FSGS) diagnosed in 2001. After several years of ...

Two-year-old Malani Dior Arose Desavieu was recently diagnosed with Focal Segmental Glomerulosclerosis, also known as FSGS.

Dominique Elston’s kidneys were failing, and dreams of becoming a nurse put on pause. Her sister, a medical student, became a ...

Travere Therapeutics stock popped Wednesday after a group of experts suggested an alternative means of measuring the success of FSGS drugs.

Data presentations highlight the results for FILSPARI®(sparsentan), the only approved kidney-targeted medicine for IgA nephropathy, when used as ...

This study will enroll subjects with diabetic nephropathy (DN) and rare glomerular kidney diseases, including focal segmental glomerulosclerosis (FSGS), treatment resistant minimal change disease ...

Among the topics to be presented will be new therapeutic approaches for glomerular diseases such as C3 glomerulopathy, IgA nephropathy, and focal segmental glomerulosclerosis, including clinical ...